Genotipagem RHD fetal no plasma materno como ferramenta não invasiva na predição do risco da doença Hemolítica Perinatal em gestantes RHD negativo
=== The management of RhD negative pregnant women is based on the premise that their fetuses may be at risk of developing hemolytic disease (DHPN), which could bring serious risks to the fetus. Invasive procedures such as amniocentesis or cordocentesis can be used to define the fetal RhD phenotype,...
Main Author: | |
---|---|
Other Authors: | |
Format: | Others |
Language: | Portuguese |
Published: |
Universidade Federal de Minas Gerais
2011
|
Online Access: | http://hdl.handle.net/1843/BUOS-8L7MQ6 |